OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Decontamination, automation, and containment are important considerations.
Near-infrared spectroscopy demonstrates process analytical technology capabilities.
Raman spectroscopy delivers real time, non-destructive process insights.
May 03, 2021
AMRI will increase R&D and manufacturing capabilities for orphan and rare disease products.
Complex formulations, personalized medicines, COVID-19 therapies, and sustainability goals are driving innovations in drug packaging.
Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery.
Breakthroughs in analytics and alternatives to traditional freeze drying promise to reshape biological development and the cold chain.
Despite the COVID-19 pandemic, the industry has made great strides in implementing serialization technologies, while technology developers are enabling more open access to real-time transportation data.
April 29, 2021
ViroCell will supply viral vectors and gene modified cells, to academic and corporate clients, for translational cell and gene therapies going into clinical trials.
ADMA will now have the ability to produce Bivigam at an expanded capacity with the same manufacturing scale, while using the same equipment, release testing assays, disposables, and labor force.
April 27, 2021
AkesoBio’s expanded manufacturing capacity, enabled by the addition of another Cytiva FlexFactory platform, will be used to meet current and future market needs in China as well as worldwide.
In addition to the traditional FOYA category awards, ISPE recognized two facilities for operational agility during the COVID-19 pandemic.
With a $5 million grant from DARPA, DNA Script and Moderna will develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the DARPA’s Nucleic Acids On-Demand World-Wide program.